{"id":"indacaterol-maleate-mometasone-furoate","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Cough"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Oral candidiasis"},{"rate":"5-10%","effect":"Upper respiratory tract infection"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Indacaterol maleate works by stimulating the beta2-adrenergic receptors in the lungs, causing bronchodilation and improving airflow. Mometasone furoate, on the other hand, reduces inflammation in the airways by inhibiting the production of pro-inflammatory cytokines.","oneSentence":"Indacaterol maleate is a long-acting beta2-adrenergic receptor agonist, while mometasone furoate is an inhaled corticosteroid.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:25.029Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD)"},{"name":"Asthma"}]},"trialDetails":[{"nctId":"NCT00556673","phase":"PHASE2","title":"Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-10","conditions":"Asthma","enrollment":31},{"nctId":"NCT00605306","phase":"PHASE2","title":"Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-01","conditions":"Asthma","enrollment":28},{"nctId":"NCT00557440","phase":"PHASE2","title":"Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-11","conditions":"Asthma","enrollment":37},{"nctId":"NCT00941798","phase":"PHASE2","title":"Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-07","conditions":"Asthma","enrollment":2283}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["QMF149"],"phase":"phase_3","status":"active","brandName":"indacaterol maleate/mometasone furoate","genericName":"indacaterol maleate/mometasone furoate","companyName":"Novartis","companyId":"novartis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Indacaterol maleate is a long-acting beta2-adrenergic receptor agonist, while mometasone furoate is an inhaled corticosteroid. Used for Chronic obstructive pulmonary disease (COPD), Asthma.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}